Mumbai: Wockhardt HospitalMumbai Central has partnered with haystackanalytics to embark on the realm of precision genomics with the help of whole exome sequencing.
By partnering with HaystackAnalytics, Wockhardt Hospital – Mumbai Central aims to harness the power of genomics to improve patient care and improve health outcomes. He Genetic Health Plan it’s a consumer-focused wellness solution developed on a fully automated AI-based bioinformatics platform. This program aims to provide people with a circuit view and personalized approach to preventative healthcare, encompassing early detection and future health risks through pathology and genomic testing. It is the first genomic preventive health test of its kind that helps analyze the entire exome, encompassing more than 7,000 genes, nearly 9,000 mutations, and important blood parameters to understand underlying disease predispositions.
Dr Virendra Chauhan, Center Director, Wockhardt Hospital, Mumbai Central, said: “This preventative healthcare solution, developed in collaboration with HaystackAnalytics, is a game changer that combines the power of pathology and genetics to deliver a personalized and holistic for health management. . We believe this solution, made possible by HaystackAnalytics’ expertise and innovation, will revolutionize the way people think about their health and empower them to take control of their wellbeing.”
Dr. Anirvan Chatterjee, CEO of HaystackAnalytics, said: “We have embarked on a transformational journey, where prevention takes precedence over cure, and people are empowered to take control of their well-being. Our effort is to change this paradigm by seamlessly integrating preventative measures into people’s lives. Through our partnership with Wockhardt Hospitals (Mumbai Central), we combine medical expertise with cutting-edge technology, paving the way for a new era in healthcare.”
